Programmable Cell Removal Helps Lab-Grown Tissues Keep Their Blood Vessels

Researchers have built a genetic circuit that removes unwanted cells from developing miniature tissues without taking those tissues apart. This approach could help scientists produce more useful laboratory models for testing drugs and studying disease. Its relevance to longevity lies in regenerative medicine and the possibility of eventually controlling which cells remain within engineered tissues.

The system, called SynBITE, uses signals inside cells to identify their type or developmental state. It then activates a controlled death program in selected cells. Researchers added a protein degradation tag to reduce unwanted activation of the killing mechanism. Trimethoprim stabilizes that component, allowing researchers to control its availability. The circuit also uses logic rules that can spare desirable cells, including those forming blood vessels.

In liver organoids, the team removed immature cells that did not produce albumin, a protein made by liver cells. Combined with genetic activation of CYP3A4, an important drug processing enzyme, this selection raised measured activity to about 60% of primary human liver cell function, versus roughly 20% without induced cell death. The improvement therefore reflects a combined intervention, not pruning alone.

Preserving tissue architecture was another important finding. Selection that spared vessel cells preserved approximately 23% more vessel length and 122% more vascular junctions in the reported comparison. This matters because breaking tissues apart for purification can destroy vascular networks. Better preserved networks could improve experimental models, although these measurements do not establish transplant readiness or benefits for patients.

Important limitations remain. Cell elimination reached about 63% in the underlying system, and selected cells still resembled fetal rather than adult liver cells. The article extrapolates to senescent cell clearance and immune aging, but those applications were not demonstrated here. Readers should view this as an early laboratory advance, not a treatment recommendation, and verify details in the original research paper.